Skip to main content

Indolizine Compound

ADVERTISEMENT
Identification
Molecular formula
C23H24N2
CAS number
852563-95-8
IUPAC name
N-[(1,2-diphenylindolizin-3-yl)methyl]-N-ethyl-ethanamine
State
State

At room temperature, this compound is typically in a stable solid state. It should be stored in a cool, dry place away from direct sunlight.

Melting point (Celsius)
123.50
Melting point (Kelvin)
396.60
Boiling point (Celsius)
385.50
Boiling point (Kelvin)
658.70
General information
Molecular weight
340.44g/mol
Molar mass
340.4420g/mol
Density
1.0834g/cm3
Appearence

This compound is typically found as a crystalline powder with a pale yellow to white coloration. It is stable under standard laboratory conditions and should be handled with care to prevent exposure to heat sources and moisture.

Comment on solubility

Solubility of N-[(1,2-diphenylindolizin-3-yl)methyl]-N-ethyl-ethanamine

The solubility of N-[(1,2-diphenylindolizin-3-yl)methyl]-N-ethyl-ethanamine is influenced by several factors, making its behavior in various solvents an interesting topic of exploration.

Key Factors Affecting Solubility:

  • Molecular Structure: The presence of multiple phenyl groups and the indolizin moiety contribute to significant hydrophobic character, potentially leading to lower solubility in aqueous solutions.
  • Polarity: The balance between hydrophobic and hydrophilic regions affects solubility. This compound may have limited solubility in polar solvents but could show enhanced solubility in organic solvents.
  • Temperature: Increasing temperature often enhances solubility for many organic compounds. It’s worth noting how solubility may vary with temperature changes for this compound.

In general, while exact solubility data for this specific compound may not be widely reported, some general trends can be observed. As a rule of thumb:

  • It is likely to be insoluble or sparingly soluble in water.
  • It may exhibit good solubility in organic solvents such as ethanol, methanol, or dichloromethane.

These considerations make the solubility of N-[(1,2-diphenylindolizin-3-yl)methyl]-N-ethyl-ethanamine a complex yet intriguing aspect of its chemistry.

Interesting facts

Interesting Facts about N-[(1,2-diphenylindolizin-3-yl)methyl]-N-ethyl-ethanamine

N-[(1,2-diphenylindolizin-3-yl)methyl]-N-ethyl-ethanamine is an intriguing compound with a unique chemical structure that captivates the interest of researchers in the field of organic chemistry. Here are some notable aspects:

  • Structure Complexity: Its molecular architecture incorporates an indolizin moiety, which contributes to its intriguing properties and reactivity. The presence of phenyl groups enhances its stability and versatility in reactions.
  • Potential Applications: Such compounds are often explored in medicinal chemistry and drug design due to their potential to interact with biological systems. There is ongoing research into their possible use as antidepressants or in the treatment of neurological disorders.
  • Research Significance: The exploration of this compound can lead to important findings in structure-activity relationships (SAR). Understanding how small changes in its structure affect biological activity can guide the development of new therapeutic agents.
  • Mechanisms of Action: It is believed that compounds with similar structures may modulate neurotransmitter systems, offering potential insights into complex mental health conditions.

As a compound associated with advanced applications in chemistry, N-[(1,2-diphenylindolizin-3-yl)methyl]-N-ethyl-ethanamine exemplifies how intricate molecular designs can open doors to innovative solutions in pharmaceuticals and materials science.

In the words of a well-known chemist, “Every compound tells a story, and understanding its narrative can lead us to groundbreaking discoveries.” This underscores the importance of in-depth research and analysis of compounds like this one.

Synonyms
BRN 0435332
INDOLIZINE, 3-((DIETHYLAMINO)METHYL)-1,2-DIPHENYL-
3-((Diethylamino)methyl)-1,2-diphenylindolizine
17613-27-3
DTXSID70170087
5-22-11-00213 (Beilstein Handbook Reference)
DTXCID6092578